Pipeline intelligence that flags
stalled accounts before deals go cold.
Pharma sales managers often discover that an account has gone cold only when the MR reports "they're not responding anymore." By that point, months of investment have produced no outcome. Pharos Gate surfaces stagnation automatically — before the deal is lost.
Pharos Gate · Pipeline intelligence that flags stalled accounts before deals go cold.
Why deals go cold
before anyone notices.
Pharma sales managers often discover that a hospital account has gone cold only when the MR reports "they're not responding anymore." By that point, 3–4 months of field investment have produced no outcome, and the window to intervene has closed. The information to prevent this exists in the system — in visit logs, in stage timestamps, in email response rates. Gate surfaces it automatically before the deal is lost.
Three capabilities. One tool.
Automated Stagnation Alerts
Proactively identifies accounts stuck beyond defined thresholds at each pipeline stage — with criticality levels and assigned representative details. Sales managers intervene before high-value opportunities go cold. Not after.
Stage Bottleneck Heatmaps
Visualises average time per stage versus regional benchmarks across territories. Reveals systemic delays enabling targeted corrective actions before they become territory-wide patterns.
MR Execution Intelligence
Representatives ranked by deal cycle speed, closure rate, and stage progression. Field visit notes mapped to account timelines. Complete picture of individual execution quality across the portfolio.
What the engagement
actually looks like.
How Pharos Gate enforces pre-promotional content compliance
A typical Gate deployment is triggered by one of three events: (1) a UCPMP investigation that identified non-compliant promotional content in the team's recent output; (2) a global parent's pre-approval requirement for India promotional content; or (3) a medical-affairs head's decision to formalise the medical-legal-regulatory (MLR) review process for all promotional content.
Pre-promotional content governance. Every piece of promotional content (HCP-facing brochures, MR detailing aids, patient-information leaflets, conference materials, digital ads, social media posts) flows through Gate before external use. The platform routes content to the appropriate reviewers (medical, legal, regulatory) with structured comment workflows, decision audit trails, and version control.
UCPMP compliance scoring. Each content piece is scored against UCPMP 2024 criteria: balance of benefit and risk information, evidence-backed claims with source citations, no comparative claims unless supported by head-to-head evidence, no over-the-counter promotion for Schedule H/H1/X drugs, no patient testimonials for prescription drugs, no gifts or hospitality offers documented in promotional materials. Content that fails any criterion is blocked from approval until remediated.
Audit trail and approval defensibility. Every reviewer comment, every decision, every revision is time-stamped and stored in an inspection-defensible audit trail. When a regulator queries "who approved this content and what evidence supported the approval?" — the answer is one click away.
Regulatory framework
Gate enforces UCPMP 2024 (India), the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954, Schedule H/H1/X drug-promotion restrictions, IFPMA Code (international parent companies), EFPIA Code (European parents), PhRMA Code (US parents), and the DPDP Act 2023 for PII-handling within HCP-facing materials.
Outcome targets
(1) UCPMP-violation incidents — target zero violations per 12-month period; (2) MLR review turnaround time — typical reduction from 14–21 days to 3–7 days per content piece; (3) Content-approval defensibility — 100% audit trail completeness on inspection.
How Pharos Gate connects
to the rest of Pharos.
Gate watches the pipeline. RouteIQ drives the field activity that fills it. Signal coaches the MRs whose deals are stalling. Pulse rolls it up for leadership.
Built for specific roles.
Nine modules. One intelligence layer.
Built for the specific frictions of pharma.
ICG's commercial and field force engagements run on RxFlow, RouteIQ, Gate, Signal, and Pulse — five tools that connect field activity to prescription outcomes.
Explore the full Pharos platform →Every ICG pharma engagement runs on some combination of these nine modules. The pilot engagement determines which ones are active from Day 1.
Start a pilot project →
Led by a pharma specialist.
IIT BHU-founded leadership team.
Every ICG pharma engagement is led personally by Aditi Tripathi — M.Pharm, IIT BHU — with Abhash, Deep and Rohit (Co-Founding Team) bringing the scientific rigour, delivery architecture and commercial lens built across 8+ years. IIT BHU pharmaceutical engineers at every level of the engagement.
60+ specialists. One process. Every deliverable in-house. Gurgaon, since 2018.
Abhash Kumar
Strategy Lead · IIT BHU + IIM Bangalore
Leads scientific strategy and quality governance. Sets the standard for scientific rigour across every engagement.
Profile →
Deep Das
Operations Lead · IIT BHU (B.Tech + M.Tech)
Owns the AI-powered delivery system — the multi-tenant operations layer that runs every pharma engagement on time and on spec.
Profile →
Rohit Gupta
Business & Growth Lead · IIT BHU + IIM Rohtak
Pharma engineer who owns business growth and the commercial lens connecting science to prescription outcomes.
Profile →
Aditi Tripathi
IIT BHU · M.Pharm
Aditi leads every pharma engagement end to end — from scoping the scientific writing architecture to governing quality across delivery. Her M.Pharm from IIT BHU means she doesn't need the science explained to her. "She explains it to everyone else."
See Pharos Gate live.
30-minute demo. No commitment.
The demo walks through sales pipeline intelligence on real (anonymised) pharma data. You see exactly how the tool fits the engagement before any commercial conversation.
